HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation

Virology

Volumn 353, Issue 2, 2006, Pages 357-365

  Yadav, Anjana ^a   Pati, Shibani ^a   Nyugen, Anhthu ^a   Barabitskaja, Oxana ^a   Mondal, Prosanta ^a   Anderson, Michael ^a   Gallo, Robert C ^a   Huso, David L ^b   Reid, William ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD28; HIV 1; Lck; Memory; Transgenic

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 2; PROTEIN BCL XL; PROTEIN KINASE LCK;

ANIMAL CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; ENZYME ACTIVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; TH1 CELL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD28; APOPTOSIS; BCL-X PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33748870040     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.05.026     Document Type: Article

References (45)

1. Acuto O., Mise-Omata S., Mangino G., and Michel F. Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor. Immunol. Rev. 192 (2003) 21-31
2. Ahmed R., and Gray D. Immunological memory and protective immunity: understanding their relation. Science 272 (1996) 54-60
3. Bandres J.C., and Ratner L. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J. Virol. 68 (1994) 3243-3249
4. Bieniasz P.D., and Cullen B.R. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74 (2000) 9868-9877
5. Bluestone J.A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2 (1995) 555-559
6. Boaz M.J., Waters A., Murad S., Easterbrook P.J., and Vyakarnam A. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 169 (2002) 6376-6385
7. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., Lindsten T., and Thompson C.B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3 (1995) 87-98
8. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., Nguyen P.L., Khoruts A., Larson M., Haase A.T., and Douek D.C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200 (2004) 749-759
9. Bretscher P., and Cohn M. A theory of self-nonself discrimination. Science 169 (1970) 1042-1049
10. Dennehy K.M., Kerstan A., Bischof A., Park J.H., Na S.Y., and Hunig T. Mitogenic signals through CD28 activate the protein kinase Ctheta-NF-kappaB pathway in primary peripheral T cells. Int. Immunol. 15 (2003) 655-663
11. Dickie P., Felser J., Eckhaus M., Bryant J., Silver J., Marinos N., and Notkins A.L. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185 (1991) 109-119
12. Gett A.V., Sallusto F., Lanzavecchia A., and Geginat J. T cell fitness determined by signal strength. Nat. Immunol. 4 (2003) 355-360
13. Greenway A., Azad A., Mills J., and McPhee D. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70 (1996) 6701-6708
14. Greenway A.L., Holloway G., McPhee D.A., Ellis P., Cornall A., and Lidman M. HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication. J. Biosci. 28 (2003) 323-335
15. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., and Allison J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356 (1992) 607-609
16. Kaech S.M., Wherry E.J., and Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev., Immunol. 2 (2002) 251-262
17. Keppler O.T., Yonemoto W., Welte F.J., Patton K.S., Iacovides D., Atchison R.E., Ngo T., Hirschberg D.L., Speck R.F., and Goldsmith M.A. Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J. Virol. 75 (2001) 8063-8073
18. Keppler O.T., Allespach I., Schuller L., Fenard D., Greene W.C., and Fackler O.T. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J. Virol. 79 (2005) 1655-1665
19. Kerstan A., and Hunig T. Cutting edge: distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cells. J. Immunol. 172 (2004) 1341-1345
20. Lanzavecchia A., and Sallusto F. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17 (2005) 326-332
21. Linsley P.S., Bradshaw J., Urnes M., Grosmaire L., and Ledbetter J.A. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J. Immunol. 150 (1993) 3161-3169
22. Lu X., Wu X., Plemenitas A., Yu H., Sawai E.T., Abo A., and Peterlin B.M. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6 (1996) 1677-1684
23. Luria S., Chambers I., and Berg P. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5326-5330
24. Manninen A., Renkema G.H., and Saksela K. Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway. J. Biol. Chem. 275 (2000) 16513-16517
25. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., and Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 (2005) 1093-1097
26. Michel F., and Acuto O. CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?. Sci. STKE (2002) E35
27. Miedema F., Petit A.J., Terpstra F.G., Schattenkerk J.K., de Wolf F., Al B.J., Roos M., Lange J.M., Danner S.A., and Goudsmit J. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J. Clin. Invest. 82 (1988) 1908-1914
28. Molina T.J., Kishihara K., Siderovski D.P., van Ewijk W., Narendran A., Timms E., Wakeham A., Paige C.J., Hartmann K.U., and Veillette A. Profound block in thymocyte development in mice lacking p56lck. Nature 357 (1992) 161-164
29. Rathmell J.C., and Thompson C.B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109 (2002) S97-S107 (Suppl.)
30. Reid W., Sadowska M., Denaro F., Rao S., Foulke Jr. J., Hayes N., Jones O., Doodnauth D., Davis H., Sill A., O'Driscoll P., Huso D., Fouts T., Lewis G., Hill M., Kamin-Lewis R., Wei C., Ray P., Gallo R.C., Reitz M., and Bryant J. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9271-9276
31. Reid W., Abdelwahab S., Sadowska M., Huso D., Neal A., Ahearn A., Bryant J., Gallo R.C., Lewis G.K., and Reitz M. HIV-1 transgenic rats develop T cell abnormalities. Virology 321 (2004) 111-119
32. Roman E., Miller E., Harmsen A., Wiley J., von Andrian U.H., Huston G., and Swain S.L. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196 (2002) 957-968
33. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22 (2004) 745-763
34. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science 248 (1990) 1349-1356
35. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat. Rev., Immunol. 2 (2002) 116-126
36. Shearer G.M., Payne S.M., Joseph L.J., and Biddison W.E. Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome. J. Clin. Invest. 74 (1984) 496-506
37. Shearer G.M., Bernstein D.C., Tung K.S., Via C.S., Redfield R., Salahuddin S.Z., and Gallo R.C. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J. Immunol. 137 (1986) 2514-2521
38. Sieg S.F., Bazdar D.A., Harding C.V., and Lederman M.M. Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease. J. Virol. 75 (2001) 9983-9985
39. Smith B.L., Krushelnycky B.W., Mochly-Rosen D., and Berg P. The HIV nef protein associates with protein kinase C theta. J. Biol. Chem. 271 (1996) 16753-16757
40. Sun Y., Schmitz J.E., Acierno P.M., Santra S., Subbramanian R.A., Barouch D.H., Gorgone D.A., Lifton M.A., Beaudry K.R., Manson K., Philippon V., Xu L., Maecker H.T., Mascola J.R., Panicali D., Nabel G.J., and Letvin N.L. Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus-induced IL-2 expression by central memory CD4+ T lymphocytes. J. Immunol. 174 (2005) 4753-4760
41. Terpstra F.G., Al B.J., Roos M.T., de Wolf F., Goudsmit J., Schellekens P.T., and Miedema F. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur. J. Immunol. 19 (1989) 667-673
42. Tuosto L., Marinari B., Andreotti M., Federico M., and Piccolella E. Vav exchange factor counteracts the HIV-1 Nef-mediated decrease of plasma membrane GM1 and NF-AT activity in T cells. Eur. J. Immunol. 33 (2003) 2186-2196
43. Veazey R.S., DeMaria M., Chalifoux L.V., Shvetz D.E., Pauley D.R., Knight H.L., Rosenzweig M., Johnson R.P., Desrosiers R.C., and Lackner A.A. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 (1998) 427-431
44. Wei P., Garber M.E., Fang S.M., Fischer W.H., and Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92 (1998) 451-462
45. Yue F.Y., Kovacs C.M., Dimayuga R.C., Parks P., and Ostrowski M.A. HIV-1-specific memory CD4+ T cells are phenotypically less mature than cytomegalovirus-specific memory CD4+ T cells. J. Immunol. 172 (2004) 2476-2486